SCHEMBL30296315

SCHEMBL30296315

Nc1cc(Cl)c(COc2ccccc2)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 7/20 0.42
▸ GRM5 P41594 2/20 0.42
▸ NR4A2 P43354 4/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ NCOA1 Q15788 1/20 0.39
▸ NCOA3 Q9Y6Q9 1/20 0.39
▸ PARP15 Q460N3 1/20 0.39
▸ PARP14 Q460N5 1/20 0.39
▸ PARP10 Q53GL7 1/20 0.39
▸ NR4A1 P22736 1/20 0.39
▸ NR4A3 Q92570 1/20 0.39
▸ SCN9A Q15858 1/20 0.39
▸ DDR1 Q08345 1/20 0.39
▸ TAAR1 Q96RJ0 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAOA P21397 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26094325 1.00 MAOB (0.42) MAOBGRM5NR4A2RAB9ANPC1
SCHEMBL8877336 0.94 MAOB (0.42) MAOBGRM5NR4A2RAB9ANPC1
SCHEMBL31207421 0.81 NR4A2 (0.40) MAOBGRM5NR4A2RAB9ANPC1
SCHEMBL30296217 0.80 GRM5 (0.39) GRM5SCN9A
SCHEMBL26095231 0.77 INPPL1 (0.44) GRM5SCN9A
SCHEMBL30296743 0.77 INPPL1 (0.44) GRM5SCN9A
SCHEMBL26093121 0.76 PTGES (0.57) MAOBNR4A2RAB9ANPC1SMN1; SMN2
SCHEMBL30296415 0.76 SCN9A (0.36) RAB9ASCN9A
SCHEMBL31207484 0.74 NR4A2 (0.43) MAOBGRM5NR4A2RAB9ANPC1
SCHEMBL15829152 0.72 CYP3A4 (0.49) MAOBNR4A2RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4702021-A1 COMPOUNDS CAPABLE OF MODULATING GPR65 Pathios Therapeutics Limited (GB) 2026-03-04 — — EP disclosed
WO-2024224064-A1 COMPOUNDS CAPABLE OF MODULATING GPR65 Pathios Therapeutics Limited (GB) 2024-10-31 — — WO disclosed
EP-4419203-A1 TRICYCLIC GPR65 MODULATORS Pathios Therapeutics Limited (GB) 2024-08-28 — — EP disclosed
CN-118451080-A Tricyclic GPR65 modulators 帕蒂奥斯治疗有限公司 2024-08-06 — — CN disclosed
WO-2023067322-A1 TRICYCLIC GPR65 MODULATORS Pathios Therapeutics Limited (GB) 2023-04-27 — — WO disclosed
Send feedback